A novel trial of topotecan, ifosfamide, and carboplatin (TIC) in children with recurrent solid tumors

Kavita Radhakrishnan(New York Medical College), Mitchell S. Cairo(New York Medical College), Lauren Harrison(Gloucestershire Hospitals NHS Foundation Trust), Johannes Wolff(The University of Texas MD Anderson Cancer Center), Alice Lee, James H. Garvin(Columbia University Irving Medical Center), Laura Gates(Children's Hospital of Orange County), Robert J. Wells, Violet Shen(Ruhr University Bochum), Erin Morris(New York Medical College)
Pediatric Blood & Cancer
November 8, 2014
10.1002/pbc.25309
Cited by 2

Related Papers

Guidelines for the Management of Pediatric and Adult Tumor Lysis Syndrome: An Evidence-Based Review
|Journal of Clinical Oncology|2008|794
The treatment of Wilms' Tumor: Results of the second national Wilms' Tumor study
|Cancer|1981|458
Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients
|Blood|2006|431
Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents
|Blood|2006|362
Phase II Study of Clofarabine in Pediatric Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia
|Journal of Clinical Oncology|2006|309